Beckman Coulter Life Sciences (Indianapolis, Indiana) has acquired Blue Ocean Biomedical, LLC, a Pembroke Pines, Florida-based manufacturer of automated flow cytometry systems and reagents.
Beckman Coulter Life Sciences (Indianapolis, Indiana) has acquired Blue Ocean Biomedical, LLC, a Pembroke Pines, Florida-based manufacturer of automated flow cytometry systems and reagents. The transaction provides Beckman Coulter Life Sciences with low complexity analyzers that integrate automated sample preparation and directly address emerging flow cytometry market trends.
Driving growth through internal product development and through the acquisition of differentiated businesses and technologies is a core strategy of Beckman Coulter Life Sciences. Blue Ocean Biomedical products complement the company’s cytometry portfolio with instruments based on a “sample in, result out” approach that represents a fundamental change in the routine clinical analysis sector.
The systems and reagents are currently not available in the U.S.; they are available for distribution in the European Union only.
Targeted Blood Lipidomics of Colorectal Cancer: An HTC-18 Interview with Jef Focant
July 26th 2024At HTC-18 in Leuven, Executive Editor of LCGC International, Alasdair Matheson, spoke to Jef Focant from the University of Liege about his talk entitled, “Targeted Blood Lipidomics of Colorectal Cancer."
Carol Robinson Awarded 2024 Lifetime Achievement European Inventor Award
July 24th 2024Carol Robinson of the University of Oxford has received the European Inventor Award 2024 for Lifetime Achievement from the European Patent Office for her work bringing mass spectrometry to structural biology.